These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Svendsen PF, Nilas L, Nørgaard K, Jensen JE, Madsbad S. Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679 [Abstract] [Full Text] [Related]
3. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrapa GG, Boscaro M. J Endocrinol Invest; 2004 May; 27(5):424-9. PubMed ID: 15279073 [Abstract] [Full Text] [Related]
9. Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome. Rocha MP, Maranhão RC, Seydell TM, Barcellos CR, Baracat EC, Hayashida SA, Bydlowski SP, Marcondes JA. Fertil Steril; 2010 Apr; 93(6):1948-56. PubMed ID: 19765700 [Abstract] [Full Text] [Related]
10. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome. Svendsen PF, Madsbad S, Nilas L, Paulsen SK, Pedersen SB. Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410 [Abstract] [Full Text] [Related]
17. Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome. Godoy-Matos AF, Vaisman F, Pedrosa AP, Farias ML, Mendonça LM, Pinheiro MF. Gynecol Endocrinol; 2009 Dec; 25(12):793-8. PubMed ID: 19905998 [Abstract] [Full Text] [Related]
18. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H. Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [Abstract] [Full Text] [Related]